Timothy B Lowinger Mersana Therapeutics, Inc. (MRSN) insider trading activity

MRSN Quotes by TradingView

Timothy B Lowinger is SVP, Chief Sci.&Tech. Officer of Mersana Therapeutics, Inc.. Currently has a direct ownership of 199,329 shares of MRSN, which is worth approximately $269,094. The most recent transaction as insider was on Apr 20, 2021, when has been sold 4,102 shares (Common Stock) at a price of $15.91 per share, resulting in proceeds of $65,263. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 199K
0% 3M change
10.52% 12M change
Total Value Held $269,094

Timothy B Lowinger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 20 2021
SELL
Open market or private sale
$65,263 $15.91 p/Share
4,102 Reduced 11.54%
31,444 Common Stock
Apr 20 2021
BUY
Exercise of conversion of derivative security
$19,854 $4.84 p/Share
4,102 Added 10.86%
33,671 Common Stock
Mar 22 2021
SELL
Open market or private sale
$143,552 $17.5 p/Share
8,203 Reduced 20.69%
31,444 Common Stock
Mar 22 2021
BUY
Exercise of conversion of derivative security
$39,703 $4.84 p/Share
8,203 Added 19.59%
33,671 Common Stock
Feb 22 2021
SELL
Open market or private sale
$164,142 $20.01 p/Share
8,203 Reduced 20.69%
31,444 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$39,703 $4.84 p/Share
8,203 Added 19.59%
33,671 Common Stock
Jan 20 2021
SELL
Open market or private sale
$176,693 $21.54 p/Share
8,203 Reduced 20.69%
31,444 Common Stock
Jan 20 2021
BUY
Exercise of conversion of derivative security
$39,703 $4.84 p/Share
8,203 Added 19.59%
33,671 Common Stock
Jan 15 2021
SELL
Payment of exercise price or tax liability
$49,013 $21.09 p/Share
2,324 Reduced 6.88%
31,444 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
-
7,917 Added 18.99%
33,768 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$12,600 $1.4 p/Share
9,000 Added 25.82%
25,851 Common Stock
Dec 21 2020
SELL
Open market or private sale
$209,997 $25.6 p/Share
8,203 Reduced 100.0%
0 Common Stock
Dec 21 2020
BUY
Exercise of conversion of derivative security
$39,703 $4.84 p/Share
8,203 Added 78.65%
2,227 Common Stock
Nov 20 2020
SELL
Open market or private sale
$189,079 $23.05 p/Share
8,203 Reduced 100.0%
0 Common Stock
Nov 20 2020
BUY
Exercise of conversion of derivative security
$39,703 $4.84 p/Share
8,203 Added 78.65%
2,227 Common Stock
Oct 21 2020
SELL
Open market or private sale
$71,768 $17.5 p/Share
4,101 Reduced 19.57%
16,851 Common Stock
Oct 21 2020
BUY
Exercise of conversion of derivative security
$19,849 $4.84 p/Share
4,101 Added 17.69%
19,078 Common Stock
Oct 20 2020
SELL
Open market or private sale
$68,667 $16.74 p/Share
4,102 Reduced 100.0%
0 Common Stock
Oct 20 2020
BUY
Exercise of conversion of derivative security
$97,012 $4.63 p/Share
20,953 Added 55.43%
16,851 Common Stock
TBL

Timothy B Lowinger

SVP, Chief Sci.&Tech. Officer
Cambridge, MA

Track Institutional and Insider Activities on MRSN

Follow Mersana Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRSN shares.

Notify only if

Insider Trading

Get notified when an Mersana Therapeutics, Inc. insider buys or sells MRSN shares.

Notify only if

News

Receive news related to Mersana Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRSN